FDCDDQ
BBIO icon

Federation des caisses Desjardins du Quebec’s BridgeBio Pharma BBIO Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$648K Buy
8,706
+1,327
+18% +$92.9K ﹤0.01% 1265
2026
Q1 		$548K Sell
7,379
-2,150
-23% -$156K ﹤0.01% 1225
2025
Q4 		$729K Buy
9,529
+1,421
+18% +$93.3K ﹤0.01% 1126
2025
Q3 		$421K Buy
+8,108
New +$395K ﹤0.01% 1300

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BBIO Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its BridgeBio Pharma (BBIO) stake by 18% in Q2 2026, buying an estimated $92.9K and bringing the position to 8,706 shares worth $648K. The position accounts for ﹤0.01% of the portfolio, ranked #1265.

Federation des caisses Desjardins du Quebec first reported a position in BBIO in Q3 2025 and has held it in 4 quarters since. The position peaked at $729K in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 8,706 shares of BridgeBio Pharma worth $648K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 1,327 BridgeBio Pharma shares in Q2 2026, an estimated $92.9K.
  • BridgeBio Pharma made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1265 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in BridgeBio Pharma in Q3 2025 and has held it in 4 quarters since.
  • Federation des caisses Desjardins du Quebec's BridgeBio Pharma position peaked at $729K in Q4 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.